A New Antioxidant Nutraceutical Compound Is Able to Reduce the Level of Prostate Pro-Inflammatory Mediators: Results from a Phase III, Placebo Controlled Trial. Arch Ital Urol Androl 2026. https://doi.org/10.4081/aiua.2026.14712.